249 related articles for article (PubMed ID: 25808668)
1. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.
Vanwolleghem T; Hou J; van Oord G; Andeweg AC; Osterhaus AD; Pas SD; Janssen HL; Boonstra A
Hepatology; 2015 Jul; 62(1):87-100. PubMed ID: 25808668
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.
Romani S; Hosseini SM; Mohebbi SR; Boonstra A; Sharifian A
J Viral Hepat; 2017 Sep; 24(9):776-788. PubMed ID: 28218976
[TBL] [Abstract][Full Text] [Related]
3. Immune response pattern varies with the natural history of chronic hepatitis B.
Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
[TBL] [Abstract][Full Text] [Related]
4. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
6. Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection.
Montanari NR; Ramírez R; Aggarwal A; van Buuren N; Doukas M; Moon C; Turner S; Diehl L; Li L; Debes JD; Feierbach B; Boonstra A
J Hepatol; 2022 Aug; 77(2):332-343. PubMed ID: 35218813
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.
Cao W; Qiu Z; Zhu T; Li Y; Han Y; Li T
J Clin Virol; 2014 Sep; 61(1):40-6. PubMed ID: 25049205
[TBL] [Abstract][Full Text] [Related]
8. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
[TBL] [Abstract][Full Text] [Related]
9. NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection.
de Groen RA; Hou J; van Oord GW; Groothuismink ZMA; van der Heide M; de Knegt RJ; Boonstra A
Antiviral Res; 2017 Apr; 140():18-24. PubMed ID: 28093337
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between the changes in immune cells and HBeAg loss following antiviral treatment in chronic hepatitis B patients].
Zheng Q; Zhu YY; Chen J; Liu YR; You J; Zeng DW; Lin S; Jiang JJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):801-6. PubMed ID: 23206296
[TBL] [Abstract][Full Text] [Related]
11. Natural history of serum HBV-RNA in chronic HBV infection.
Wang J; Yu Y; Li G; Shen C; Li J; Chen S; Zhang X; Zhu M; Zheng J; Song Z; Wu J; Shao L; Meng Z; Wang X; Huang Y; Zhang J; Qiu C; Zhang W
J Viral Hepat; 2018 Sep; 25(9):1038-1047. PubMed ID: 29633430
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.
Jaroszewicz J; Calle Serrano B; Wursthorn K; Deterding K; Schlue J; Raupach R; Flisiak R; Bock CT; Manns MP; Wedemeyer H; Cornberg M
J Hepatol; 2010 Apr; 52(4):514-22. PubMed ID: 20207438
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of hepatitis B surface antigen quantitation in the natural history of chronic hepatitis B virus infection.
Tan Z; Li M; Kuang X; Tang Y; Fan Y; Deng G; Wang Y; He D
J Clin Virol; 2014 Apr; 59(4):228-34. PubMed ID: 24529415
[TBL] [Abstract][Full Text] [Related]
17. T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO.
Bayard F; Godon O; Nalpas B; Costentin C; Zhu R; Soussan P; Vallet-Pichard A; Fontaine H; Mallet V; Pol S; Michel ML
J Viral Hepat; 2012 Dec; 19(12):872-80. PubMed ID: 23121366
[TBL] [Abstract][Full Text] [Related]
18. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
Sprengers D; van der Molen RG; Kusters JG; Hansen B; Niesters HG; Schalm SW; Janssen HL
J Med Virol; 2006 May; 78(5):561-8. PubMed ID: 16555293
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
[TBL] [Abstract][Full Text] [Related]
20. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
